AIC
ALDX icon

AWM Investment Company’s Aldeyra Therapeutics ALDX Stock Holding History

AWM Investment Company’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-912,610
Closed -$4.56M – 93
2017
Q1 		$4.56M Hold
912,610
– – 0.85% 37
2016
Q4 		$4.88M Sell
912,610
-5,200
-0.6% -$30.5K 0.96% 37
2016
Q3 		$7.21M Hold
917,810
– – 1.32% 24
2016
Q2 		$5.22M Buy
+917,810
New +$5.13M 1.12% 31

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

AWM Investment Company's ALDX Position: Q2 2017 in Review

AWM Investment Company sold out of Aldeyra Therapeutics (ALDX) in Q2 2017, closing a stake of 912,610 shares — an estimated $4.56M sold.

AWM Investment Company first reported a position in ALDX in Q2 2016 and held it in 4 quarters. The position peaked at $7.21M in Q3 2016. 26 funds tracked by Wall St. Rank hold ALDX as of Q2 2017.

  • AWM Investment Company reported no remaining Aldeyra Therapeutics position as of Q2 2017 after selling out during the quarter.
  • AWM Investment Company sold 912,610 Aldeyra Therapeutics shares in Q2 2017, an estimated $4.56M.
  • AWM Investment Company first reported a position in Aldeyra Therapeutics in Q2 2016 and held it in 4 quarters.
  • AWM Investment Company's Aldeyra Therapeutics position peaked at $7.21M in Q3 2016.
  • 26 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2017.

Based on AWM Investment Company's 13F filing for Q2 2017, filed 14 Aug 2017.